Vaccine News and Research

Latest Vaccine News and Research

Oxford researchers demonstrate the feasibility of increasing the speed and volume of vaccine production

Oxford researchers demonstrate the feasibility of increasing the speed and volume of vaccine production

4 Jan 2022
Experts cautiously optimistic about risks of Delta-Omicron mutations mix

Experts cautiously optimistic about risks of Delta-Omicron mutations mix

4 Jan 2022
SARS-CoV-2 mRNA vaccine boosters crucial in maintaining neutralizing antibodies in HCPs

SARS-CoV-2 mRNA vaccine boosters crucial in maintaining neutralizing antibodies in HCPs

4 Jan 2022
Israeli study confirms drop in BNT162b2 efficacy after six months

Israeli study confirms drop in BNT162b2 efficacy after six months

4 Jan 2022
CDC updates COVID-19 vaccine recommendations to ensure the best possible protection for Americans

CDC updates COVID-19 vaccine recommendations to ensure the best possible protection for Americans

4 Jan 2022
Efficacy of antibodies induced by natural infection, vaccination, or both against SARS-CoV-2 Omicron and Beta variants

Efficacy of antibodies induced by natural infection, vaccination, or both against SARS-CoV-2 Omicron and Beta variants

4 Jan 2022
Exercise performance in vaccinated and unvaccinated individuals previously infected with SARS-CoV-2

Exercise performance in vaccinated and unvaccinated individuals previously infected with SARS-CoV-2

4 Jan 2022
Study suggests increased vaccine breakthrough for SARS-CoV-2 Omicron variant in Houston, Texas

Study suggests increased vaccine breakthrough for SARS-CoV-2 Omicron variant in Houston, Texas

4 Jan 2022
In vitro effect of several antiviral drugs against various SARS-CoV-2 variants of concern

In vitro effect of several antiviral drugs against various SARS-CoV-2 variants of concern

4 Jan 2022
Study finds pan-sarbecovirus nanobodies can enhance development of super-immunity

Study finds pan-sarbecovirus nanobodies can enhance development of super-immunity

4 Jan 2022
SARS-CoV-2 spike T cell responses from vaccines or infection remain robust against Omicron

SARS-CoV-2 spike T cell responses from vaccines or infection remain robust against Omicron

3 Jan 2022
Very high rates of asymptomatic infection with Omicron compared to prior SARS-CoV-2 variants

Very high rates of asymptomatic infection with Omicron compared to prior SARS-CoV-2 variants

3 Jan 2022
SARS-CoV-2 differs from other betacoronaviruses in a key IRE1α/XBP1 pathway

SARS-CoV-2 differs from other betacoronaviruses in a key IRE1α/XBP1 pathway

3 Jan 2022
Production of molecular probes of spike and subdomains for all SARS-CoV-2 variants

Production of molecular probes of spike and subdomains for all SARS-CoV-2 variants

3 Jan 2022
The impact of natural selection on sequence diversity in SARS-CoV-2

The impact of natural selection on sequence diversity in SARS-CoV-2

3 Jan 2022
Modeling shows SARS-CoV-2 Omicron will place a severe burden on UK's health services

Modeling shows SARS-CoV-2 Omicron will place a severe burden on UK's health services

3 Jan 2022
CDC report shows COVID vaccines safe for children, serious side effects rare

CDC report shows COVID vaccines safe for children, serious side effects rare

3 Jan 2022
Omicron spike-specific binding antibodies attenuate disease, despite increasing transmission

Omicron spike-specific binding antibodies attenuate disease, despite increasing transmission

3 Jan 2022
T-cell responses to SARS-CoV-2 Omicron variant confer protection to vaccinated individuals

T-cell responses to SARS-CoV-2 Omicron variant confer protection to vaccinated individuals

3 Jan 2022
SARS-CoV-2 Omicron variant highly resistant to vaccine-elicited and therapeutic antibodies

SARS-CoV-2 Omicron variant highly resistant to vaccine-elicited and therapeutic antibodies

3 Jan 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback